[go: up one dir, main page]

DE598573C - Process for the preparation of a vaccine for newborn animals for vaccination against trypanosomal diseases - Google Patents

Process for the preparation of a vaccine for newborn animals for vaccination against trypanosomal diseases

Info

Publication number
DE598573C
DE598573C DESCH99771D DESC099771D DE598573C DE 598573 C DE598573 C DE 598573C DE SCH99771 D DESCH99771 D DE SCH99771D DE SC099771 D DESC099771 D DE SC099771D DE 598573 C DE598573 C DE 598573C
Authority
DE
Germany
Prior art keywords
vaccine
trypanosomes
blood
preparation
newborn animals
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DESCH99771D
Other languages
German (de)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CLAUS SCHILLING DR
Original Assignee
CLAUS SCHILLING DR
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CLAUS SCHILLING DR filed Critical CLAUS SCHILLING DR
Priority to DESCH99771D priority Critical patent/DE598573C/en
Application granted granted Critical
Publication of DE598573C publication Critical patent/DE598573C/en
Priority to DESCH111932D priority patent/DE653680C/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/395Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39575Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from other living beings excluding bacteria and viruses, e.g. protozoa, fungi, plants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/002Protozoa antigens
    • A61K39/005Trypanosoma antigens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Botany (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Description

Verfahren zur Herstellung eines Impfstoffes für neugeborene Tiere zur Schutzimpfung gegen Trypanosomenkrankheiten Zweck des Verfahrens ist die Herstellung eines Schutzmittels für Zug- und Lasttiere gegen die Wirkung der als Trypanosomen bekannten Krankheitserreger.Process for the preparation of a vaccine for newborn animals for vaccination against trypanosomal diseases The purpose of the process is production a protective agent for draft and pack animals against the action of the trypanosomes known pathogens.

Das Verfahren besteht in folgendem: An einem neugeborenen Pferde-, Esel- oder Mäultierfohlen oder Kalb läßt man innerhalb der ersten i o Lebenstage infizierte Tsetsefliegen (Glossinen) saugen. Nach etwa i o Tagen treten dann die Krankheitserreger (Trypanosomen) im Bluffe auf. Nun wird das Tier mit einem bekannten Arzneimittel, z. B. dem unter der Bezeichnung Antimosan bekannten Antimon-Komplexsalz Heyden, das die Trypanosomen abzutöten vermag, unter Anwendung einer Dosis behandelt, welche die Erreger nicht völlig abtötet, sondern nur für einige Zeit zum Verschwinden. bringt. Es wird sich nach solcher zur sterilen Heilung nicht genügenden Behandlung bald ein Rückfall .mit Krankheitserscheinungen bei dem Tiere einstellen, aber dieses übersteht die Krankheit, die Fieberkurve gleicht sich aus, das Gewicht steigt, das Tier erscheint äußerlich als völlig gesund, beherbergt aber in seinem Blute die Erreger (latente Infektion). Dieser Zustand ist die Bedingung und Grundlage der Immunität gegen neue sog. Superinfektionen. Wenn, dieses Stadium der Infektion erreicht ist, sind das Blut bzw. die darin enthaltenen Trypanosomen als Impfstoff für neugeborene Tiere geeignet. Beispiele z. Fohlen i, geboren 'am 27. IX. 1930, wird am 3., 4., 5. und 6. X. 30 von mit Trypanosoma congolense infizierten Tsetsefiiegen gestochen. Am 13. X. erscheinen Trypanosomen im Blut. Am 15. X. wird das obengenannte Arzneimittel (1/¢ der abheilenden Dosis) subkutan injiziert; desgleichen am 17. X., also insgesamt . die halbe zur Heilung eben genügende Dosis. Blut am 16. X. und die folgenden 5 Tage parasitenfrei; vom 22. X. ab enthält das Blut wieder Trypanosomen, die von jetzt ab dauernd, wenn auch in wechselnder und stets sehr geringer Menge im Blute nachweisbar sind. Das Gewicht steigt von 36,5kg bei der Geburt auf 352kg am 18. IV. 32. Die Temperatur ist bis zum 27. XI. 3o unregelmäßig fieberhaft, dann normal, nur von einigen i bis 2 Tage dauernden Erhebungen in Abständen von mehreren Wochen unterbrochen. Letzte kleine Schwankung am 2. 1I. 32.The procedure consists of the following: Infected tsetse flies (glossins) are suckled on a newborn horse, donkey or mule foal or calf within the first 10 days of life. After about 10 days the pathogens (trypanosomes) appear in the bluff. The animal is now treated with a known drug, e.g. B. the antimony complex salt known as Antimosan Heyden, which is able to kill the trypanosomes, treated using a dose that does not kill the pathogens completely, but only for some time to disappear. brings. After such treatment, which is not sufficient for sterile healing, the animal will soon have a relapse with symptoms of illness, but this will survive the illness, the temperature curve will even out, the weight will increase, the animal appears outwardly to be completely healthy, but is sheltered in its own The pathogens bleed (latent infection). This condition is the condition and basis of immunity against new so-called superinfections. When this stage of infection has been reached, the blood or the trypanosomes it contains are suitable as a vaccine for newborn animals. Examples e.g. Foal i, born 'on the 27th IX. 1930, was stung on 3rd, 4th, 5th and 6th X. 30 of Tsetsefiiegen infected with Trypanosoma congolense. On the 13th of October, trypanosomes appear in the blood. On the 15th of October the above-mentioned drug (1 / ¢ of the healing dose) is injected subcutaneously; also on 17th October, that is, in total. half the dose just enough for a cure. Blood on October 16 and the following 5 days free of parasites; from 22nd October the blood again contains trypanosomes, which from now on are continuously detectable in the blood, even if in varying and always very small quantities. The weight increases from 36.5kg at birth to 352kg on April 18th. 32nd The temperature is up to XIth 27th. 3o irregularly feverish, then normal, interrupted only by a few 1 to 2 day surveys at intervals of several weeks. Last small fluctuation on January 2nd. 32.

2. Fohlen 2, geboren am 9. IV. 1932, erhält am 18. IV. 5 ccm Blut von Fohlen i unter die Hauff gespritzt. Am 6. V. spärliche Trypanosomen im Blut, die aber gleich wieder verschwinden. Temperaturschwankungen am 11. V. (4o,1) und 23. V. (4o,5), sonst normal. Vom 9. VI. bis 3. VII. unregelmäßiges Fieber, spärliche Trypanosomen im Blute, die von da ab dauernd im Blute nachweisbar bleiben. Vom 4. VII. ab normale Temperaturen, nur eine Zacke am i5./16. VIII. Das Gewicht steigt von 65 kg hei der Geburt auf 134 kg am 26. VIII. Am i. bis 5. IX. 32 wird das Fohlen von Tsetsefliegen gestochen, welche Trypanosoma congolense enthalten. Im Anschluß daran wird keine Vermehrung der Trypanosomen im Blute beobachtet, während ein von den gleichen Fliegen gestochenes anderes Fohlen nach 9 Tagen zu fiebern beginnt und an diesem Tage massenhafte Trypanosomen im Blute aufweist.2. Foal 2, born on April 9, 1932, receives 5 ccm of blood on April 18 of foals i injected under the hauff. On the 6th V. sparse trypanosomes in the blood, but they disappear again immediately. Temperature fluctuations on the 11th V. (4o, 1) and 23rd V. (4o, 5), otherwise normal. From June 9th up to 3. VII. irregular fever, scanty Trypanosomes in the blood, which from then on remain permanently detectable in the blood. From the 4. VII. From normal temperatures, only one point on the 15th / 16th. VIII. The weight increases from 65 kg at birth to 134 kg on August 26th. to 5. IX. The foal will be 32 stung by tsetse flies containing Trypanosoma congolense. In connection no increase in the trypanosomes in the blood is observed, while one of Another foal stung by the same flies begins to develop a fever after 9 days and has massive trypanosomes in the blood on that day.

Fohlen 2 hatte also durch die Impfung mit dem Blute des Fohlens i eine latente Infektion und dadurch eine Immunität gegen die Superinfektion mit Trypanosoma congolense erworben.Foal 2 thus had i due to the vaccination with the foal's blood a latent infection and thereby immunity to the superinfection with Trypanosoma congolense acquired.

An dem Verfahren ist neu: -i. daß zur Gewinnung des Impfstoffes neugeborene Tiere verwendet werden. Die bisher veröffentlichten Verfahren (s. Cl. S c h i 11 i n g, Deutsche med. Wochenschr. i 9 i 2, Nr. i, und derselbe in Handbuch der pathog. 1VEkroorg. Kolle, Kraus, Uhlenhuth, -III. Aufl., Bd.VIII, S.95; Braun u. Teichmann, Versuche zur Immunisierung gegen Trypanosomen, 19 12, S. i bis 23) haben dem Alter der den Impfstoff liefernden Tiere keine Bedeutung beigelegt.The procedure is new: -i. that newborn animals are used to obtain the vaccine. The previously published procedures (see Cl. S chi 11 ing, Deutsche med. Wochenschr. I 9 i 2, No. i, and the same in the manual of pathog. 1VEkroorg. Kolle, Kraus, Uhlenhuth, -III. Ed., Vol .viii, p.95;. brown & Teichmann, attempts to immunize against trypanosomes, 1 9 12, p i to 23) have the age of the vaccine delivered animals settled no meaning.

2. daß zur Infektion des den Impfstoff liefernden Tieres der Stich infizierter Tsetsefliegen verwendet wird. Bisher wurde, wenn lebende Trypanosomen als Impfstoff verwendet wurden (Robert K o c h, Cl. S c h i 1-1 i n g a. a. O.), die Infektion des Impfstoffspenders durch Übertragung von Blut mit der Injektionsspritze vorgenommen.2. That the sting causes the infection of the animal supplying the vaccine infected tsetse flies is used. So far, if has been living trypanosomes were used as a vaccine (Robert K o c h, Cl. S c h i 1-1 i n g a. a. O.), infection of the vaccine donor by transferring blood with the injection syringe performed.

3. daß die so gesetzte Infektion durch ein Arzneimittel nicht abgeheilt, sondern nur so weit beeinflußt wird, daß sich ,eine latente Infektion ergibt. Paul E h r 1 i c h u. a. haben Immunität durch sterilisierende Abheilung der Trypanosomeninfektion, also völlige Vernichtung der Erreger im Tierkörper erzielt; beim' vorliegenden Verfahren aber wird keine Abheilung, sondern nur eine vorübergehende Zurückdrängung der Infektion vorgenommen, die bei neugeborenen Tieren (s. u.) zur labilen Infektion führt.3. that the infection thus set is not healed by a drug, it is only influenced to the extent that a latent infection results. Paul E h r 1 i c h u. A. have immunity through sterilizing healing of the trypanosome infection, thus achieved complete destruction of the pathogens in the animal body; in the present proceedings but there is no healing, only a temporary suppression of the infection carried out, which leads to unstable infection in newborn animals (see below).

4. daß der Impfstoff - das Blut eines nach Abschnitt i bis 3 vorbehandelten neugeborenen Tieres - nicht auf erwachsene, sondern wieder auf neugeborene Tiere verimpft wird.4. That the vaccine - the blood of a pretreated according to Sections i to 3 newborn animal - not to adult, but again to newborn animals is inoculated.

Claims (1)

PATENTANSPRUCH': Verfahren zur Herstellung seines Impfstoffes für neugeborene Tiere zur Schutzimpfung gegen Trypanosomenkrankheiten, dadurch gekennzeichnet, daß lein neugeborenes Fohlen oder Kalh durch den. Stich von mit Trypanosomen infizierten Tsetseflieg en (Glossium) infiziert und dann mit einem gegen Trypanosomen wirksamen Arzneimittel so behandelt wird, daß keine sterile Heilung, sonderm eine labile Infektion folgt, worauf das trypanosomenhaltige Blut dieses Tieres in üblicher Weise gewonnen wird.PATENT CLAIM ': Process for the manufacture of his vaccine for newborn animals for vaccination against trypanosomal diseases, characterized in that that a newborn foal or Kalh by the. Sting from infected with trypanosomes Tsetse flies (Glossium) infected and then with an effective against trypanosomes Medicinal product is treated in such a way that no sterile cure, but rather a labile infection followed, whereupon the trypanosome-containing blood of this animal was obtained in the usual way will.
DESCH99771D 1932-12-07 1932-12-07 Process for the preparation of a vaccine for newborn animals for vaccination against trypanosomal diseases Expired DE598573C (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
DESCH99771D DE598573C (en) 1932-12-07 1932-12-07 Process for the preparation of a vaccine for newborn animals for vaccination against trypanosomal diseases
DESCH111932D DE653680C (en) 1932-12-07 1937-01-30 Process for the preparation of a vaccine for newborn animals to be vaccinated against trypanosomes

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DESCH99771D DE598573C (en) 1932-12-07 1932-12-07 Process for the preparation of a vaccine for newborn animals for vaccination against trypanosomal diseases
DESCH111932D DE653680C (en) 1932-12-07 1937-01-30 Process for the preparation of a vaccine for newborn animals to be vaccinated against trypanosomes

Publications (1)

Publication Number Publication Date
DE598573C true DE598573C (en) 1934-06-13

Family

ID=32657648

Family Applications (2)

Application Number Title Priority Date Filing Date
DESCH99771D Expired DE598573C (en) 1932-12-07 1932-12-07 Process for the preparation of a vaccine for newborn animals for vaccination against trypanosomal diseases
DESCH111932D Expired DE653680C (en) 1932-12-07 1937-01-30 Process for the preparation of a vaccine for newborn animals to be vaccinated against trypanosomes

Family Applications After (1)

Application Number Title Priority Date Filing Date
DESCH111932D Expired DE653680C (en) 1932-12-07 1937-01-30 Process for the preparation of a vaccine for newborn animals to be vaccinated against trypanosomes

Country Status (1)

Country Link
DE (2) DE598573C (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE957596C (en) * 1954-09-10 1957-02-07 Bayer Ag Process for the production of antigens from the foot and mouth disease vaccine

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE957596C (en) * 1954-09-10 1957-02-07 Bayer Ag Process for the production of antigens from the foot and mouth disease vaccine

Also Published As

Publication number Publication date
DE653680C (en) 1937-11-30

Similar Documents

Publication Publication Date Title
DE1793315C2 (en)
Briggs et al. Comparison of the effect of diisopropyl phenol (ICI 35 868) and thiopentone on response to somatic pain
Asakura et al. Arakawa's Reaction and Toxicity of Human Milk 42nd Report of the Peroxidase Reaction
DE598573C (en) Process for the preparation of a vaccine for newborn animals for vaccination against trypanosomal diseases
Box et al. Use of CT1341 anaesthetic ('Saffan') in monkeys
DE2334376A1 (en) IMMUNOLOGICAL PRODUCT, ITS USE AND METHOD FOR ITS MANUFACTURING
DE833673C (en) Method for producing a pig cholera lymph
Saunders Derris Root Treatment of Scabies
Lomholt Notes on the pharmacology of bismuth, with reference to its employment in the therapy of syphilis
Ottosson The effect of xylocain in electric convulsive treatment
AT63422B (en) Process for the preparation of a serum against calf agitation.
AT142697B (en) Process for the preparation of a serum against the consequences of fire.
DE1174016B (en) Process for the production of a live vaccine against foot and mouth disease
Stahnke The venomous effects of some Arizona scorpions
DE722872C (en) Process for the preparation of an agent against foot and mouth disease
DE10008619A1 (en) Microorganism-free Immunoglobulin (Ig) G preparation produced from animal blood, used for prevention of bacterial and viral infections in animal husbandry
Lekeux et al. Comparison of different treatments of atrial fibrillation in the horse
DE3043909A1 (en) MEDICINAL PRODUCTS CONTAINING A COMBINATION OF ACETYLSALICYL ACID AND HEPTAMINOL
DE279213C (en)
DE864439C (en) Process for the production of a detoxified toxin from the Siphonospora polymorpha by Brehmer
AT140479B (en) Process for the production of a preparation by means of which dental and jaw diseases can be prevented or treated.
DE729116C (en) Process for the production of sterile bandages or sterile catgut
DE394735C (en) Process for the production of vaccines or immune sera, with the exception of those against cancer
Chamberlain Arachnoidism As Applied To New Zealand Spiders: A PRELIMINARY NOTE
AT64786B (en) Process for producing an X-ray toxin.